Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

Recent advances in Wilms tumor genetics.

Dome JS, Coppes MJ.

Curr Opin Pediatr. 2002 Feb;14(1):5-11. Review.

PMID:
11880727
2.

Molecular genetics of Wilms' tumour.

Tay JS.

J Paediatr Child Health. 1995 Oct;31(5):379-83. Review.

PMID:
8554853
3.

Frequent association of beta-catenin and WT1 mutations in Wilms tumors.

Maiti S, Alam R, Amos CI, Huff V.

Cancer Res. 2000 Nov 15;60(22):6288-92.

4.

Genetics of Wilms' tumor.

Coppes MJ, Egeler RM.

Semin Urol Oncol. 1999 Feb;17(1):2-10. Review.

PMID:
10073400
5.

Molecular genetics of Wilms tumor.

Grundy P, Coppes MJ, Haber D.

Hematol Oncol Clin North Am. 1995 Dec;9(6):1201-15.

PMID:
8591961
6.

Cytogenetics and molecular genetics of Wilms' tumor of childhood.

Slater RM, Mannens MM.

Cancer Genet Cytogenet. 1992 Jul 15;61(2):111-21. Review.

PMID:
1322233
7.

CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms' tumors.

Li CM, Kim CE, Margolin AA, Guo M, Zhu J, Mason JM, Hensle TW, Murty VV, Grundy PE, Fearon ER, D'Agati V, Licht JD, Tycko B.

Am J Pathol. 2004 Dec;165(6):1943-53.

8.

Myogenesis in Wilms' tumors is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signaling pathway.

Fukuzawa R, Heathcott RW, Sano M, Morison IM, Yun K, Reeve AE.

Pediatr Dev Pathol. 2004 Mar-Apr;7(2):125-37. Epub 2004 Mar 4. Erratum in: Pediatr Dev Pathol. 2004 Sep-Oct;7(5):549.

PMID:
14994125
9.

Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.

Park S, Tomlinson G, Nisen P, Haber DA.

Cancer Res. 1993 Oct 15;53(20):4757-60.

10.

Molecular genetic pathways to Wilms tumor.

Pritchard-Jones K.

Crit Rev Oncog. 1997;8(1):1-27. Review.

PMID:
9516084
11.

[Hereditary renal tumors: Wilms' tumor--congenital anomalies' syndrome].

Tsuchida Y, Yokomori K, Choi SH.

Nihon Rinsho. 1995 Nov;53(11):2742-8. Review. Japanese.

PMID:
8538037
12.

An overview of the clinical and molecular genetics of Wilms' tumor.

Grundy P, Coppes M.

Med Pediatr Oncol. 1996 Nov;27(5):394-7. Review. No abstract available.

PMID:
8827064
13.

A constitutional BWS-related t(11;16) chromosome translocation occurring in the same region of chromosome 16 implicated in Wilms' tumors.

Newsham I, Kindler-Röhrborn A, Daub D, Cavenee W.

Genes Chromosomes Cancer. 1995 Jan;12(1):1-7.

PMID:
7534105
14.

Mutational activation of the beta-catenin proto-oncogene is a common event in the development of Wilms' tumors.

Koesters R, Ridder R, Kopp-Schneider A, Betts D, Adams V, Niggli F, Briner J, von Knebel Doeberitz M.

Cancer Res. 1999 Aug 15;59(16):3880-2.

15.

Beck-Wiedemann syndrome and Wilms' tumour.

Ward A.

Mol Hum Reprod. 1997 Feb;3(2):157-68. Review.

PMID:
9239720
16.

Molecular biology of Wilms' tumor.

Koo HP, Hensle TW.

Urol Clin North Am. 1993 May;20(2):323-31. Review.

PMID:
8388135
17.

Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5.

Koufos A, Grundy P, Morgan K, Aleck KA, Hadro T, Lampkin BC, Kalbakji A, Cavenee WK.

Am J Hum Genet. 1989 May;44(5):711-9.

18.

Familial Wilms tumor.

Ruteshouser EC, Huff V.

Am J Med Genet C Semin Med Genet. 2004 Aug 15;129C(1):29-34. Review.

PMID:
15264270
19.

Nuclear accumulation of beta-catenin protein in Wilms' tumours.

Koesters R, Niggli F, von Knebel Doeberitz M, Stallmach T.

J Pathol. 2003 Jan;199(1):68-76.

PMID:
12474228
20.

Introduction to the genetics of primary renal tumors in children.

Knudson AG Jr.

Med Pediatr Oncol. 1993;21(3):193-8. Review.

PMID:
8383279

Supplemental Content

Support Center